Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Net income	$ 3,599	$ 5,268
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	8,694	9,103
Stock-based compensation expense	3,992	4,276
Deferred taxes	(1,552)	(2,247)
Interest on finance lease obligations	6	10
Impairments related to exit and closure of facilities	219	0
Gain on disposal of property and equipment	0	(22)
Other	43	63
Changes in operating assets and liabilities:
Accounts receivable	(7,405)	(5,654)
Inventories	(698)	802
Prepaid expenses and other	517	(359)
Income taxes	3,702	5,457
Accounts payable	758	(138)
Accrued liabilities and other	6,504	4,779
Net cash provided by operating activities	18,379	21,338
Investing activities
Purchases of property, equipment and other capital assets	(1,262)	(2,587)
Proceeds from sales of property, equipment and other capital assets	0	22
Purchases of marketable securities	(6,552)	0
Proceeds from call redemptions and maturities of marketable securities	4,905	6,984
Net cash (used in) provided by investing activities	(2,909)	4,419
Financing activities
Proceeds from issuance of common stock from equity plans	287	0
Purchases of shares withheld for tax obligations	(1,248)	(533)
Repurchases of common stock	(20,890)	(16,013)
Principal repayments of finance lease obligations	(76)	(73)
Net cash used in financing activities	(21,927)	(16,619)
Effect of exchange rate changes on cash and cash equivalents	78	(124)
Net (decrease) increase in cash and cash equivalents	(6,379)	9,014
Cash and cash equivalents, beginning of period	89,071	83,790
Cash and cash equivalents, end of period	$ 82,692	$ 92,804